Biomedicine Congress - Biology Congress - Medicine Congress

mahdieh salimi

Department of Medical Genetics, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
tehran, iran

Abstracts, mahdieh salimi [Author]

---

• MiR-217 as a biomarker candidate in Iranian breast cancer patients

  Cancer; Prevention, Diagnosis and Treatment

  Despite the advances in diagnosis and new treatments such as targeted therapies, breast cancer is still the most common ...Read more

• Dysregulation of miR-21 as a possible prognostic marker in aggressive breast cancer

  Medical Genetics

  Breast cancer is the most common cancer and leading cause of cancer death in women worldwide, accounting for 25.1% of a...Read more